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 [Mark Cronly] 1 
DEVELOPMENT AND VALIDATION OF A RAPID MULTI-CLASS 
METHOD FOR THE CONFIRMATION OF FOURTEEN PROHIBITED 
MEDICINAL ADDITIVES IN PIG AND POULTRY COMPOUND 
FEED BY LIQUID CHROMATOGRAPHY TANDEM MASS 
SPECTROMETRY 
Author Name Mark Cronly,*a,b Patrice Behana, Barry Foley a, Marella Gallagherb Sean Earleyb 
Paula Shearanb Edward Maloneb and Liam Regan b 
Abstract 
A confirmatory method has been developed to allow for the analysis of fourteen prohibited 
medicinal additives in pig and poultry compound feed. These compounds are prohibited for 
use as feed additives although some are still authorised for use in medicated feed. Feed 
samples are extracted by acetonitrile with addition of sodium sulphate. The extracts undergo 
a hexane wash to aid with sample purification. The extracts are then evaporated to dryness 
and reconstituted in initial mobile phase. The samples undergo an ultracentrifugation step 
prior to injection onto the LC-MS/MS system and are analysed in a run time of 26 minutes. 
The LC-MS/MS system is run in MRM mode with both positive and negative electrospray 
ionisation. The method was validated over three days and is capable of quantitatively 
analysing for metronidazole, dimetridazole, ronidazole, ipronidazole, chloramphenicol, 
sulfadiazine, sulfamethazine, dinitolimide, ethopabate, carbadox and clopidol. The method is 
also capable of qualitatively analysing for tylosin, virginiamycin and avilamycin. A level of 100 
µg kg-1 was used for validation purposes and the method is capable of analysing to this level 
for all the compounds. Validation criteria of trueness, precision, repeatability and 
reproducibility along with measurement uncertainty are calculated for all analytes. 
Keywords: Antibiotics; pig and poultry compound feed; lc-ms/ms; validation. 
1. Introduction  
The use of many antibiotics, coccidiostats and 
antibacterial growth promoters as feed additives has 
been prohibited in Europe since 2006 by Commission 
Recommendation 2005/925/EC. This recommendation 
lists medicinal substances that should be monitored and 
the substances are divided into two groups; medicinal 
substances authorised as feed additives for certain 
animal species or categories and medicinal substances 
no longer authorised as feed additives. This paper 
focuses on the analysis of the second group of medicinal 
substances specifically antibacterial growth promoters 
(AGPs) which are no longer authorised as feed 
additives; this group consists of various different types of 
compounds. Nitroimidazoles and chloramphenicol are 
banned for use in food producing animals. Other AGPs 
which include virginiamycin and tylosin are prohibited for 
use as feed additives. Finally some compounds such as 
sulfonamides are only permitted for use in medicated 
feed.  The structures for all fourteen analytes are 
presented in Tables 1a and 1b. 
Nitroimidazoles and chloramphenicol are classified as 
prohibited substances in table 2 of Commission 
Regulation 2010/37/EC and therefore prohibited for the 
use in animal husbandry. As a result these should not be 
found in animal feeds. While there are single class 
methods for the analysis of some of compounds [Vincent 
et al., 2008; Galarini et al., 2009; Pecorelli et al., 2003; 
Barbosa et al., 2007; van Holthoon et al., 2010] there 
are very few published methods for nitroimidazoles and 
chloramphenicol in animal feed. Capitan-Vallvey et al., 
2007 describes a method for the analysis of 
nitroimidazoles in feed by LC-MS and Vinas et al., 2006 
describes a method for chloramphenicol in feed by LC-
photo diode array detector. The use of 5 AGPs including 
tylosin and virginiamycin were prohibited for this use in 
Council Regulation 2821/98. As a result there are some 
published methods for the analysis of these compounds. 
Van Poucke et al. described a method for the analysis of 
tylosin and virginiamycin in feed by LC-MS/MS [Van 
Poucke et al., 2003 Van Poucke et al., 2005] and 
Civitareale et al., 2004 describes a method for the 
analysis of tylosin by LC-UV/DAD. Other medicinal 
additives listed in 2005/925/EC also have LC methods 
for their analysis such as clopidol/nicarbazin [Dusi et al., 
2000], amprolium/ethopabate [Tan et al., 1996] and 
carbadox [Kesiunaite et al., 2008; Hutchinson et al., 
2005] while for compounds such as dinitolimide no  
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Table 1a: Molecular Structures, Retention time (Rt), 
Precursor and Product ions and typical ion ratios for all 
11 analytes             
                 
 
 
 
 
 
 
Compound Molecular Structure Rt Precursor Ion (M/z) 
Product 
Ions (M/z) 
Collision 
Energy 
124 18 
Ipronidazole (IPZ)                                
2-isopropyl-1-methyl-5-nitroimidazole 
 
 
 
9.90 170 
109 25 
96 18 
Dimetridazole (DMZ)                                            
1, 2-dimethyl-5-nitroimidazole  2.83 142 
81 28 
82 25 Metronidazole (MNZ)                                    
1-(2-hydroxyethyl)-2-methyl-5-
nitroimidazole 
 1.95 172 
128 15 
140 15 Ronidazole (RNZ)                                 
1-methyl-2-[(carbamoyloxy) methyl]-
5-nitroimidazole 
 2.21 201 
110 18 
257 18 Chloramphenicol (CAP)                
2,2-dichloro-N-[(1R,2R)-2-hydroxy-1-
(hydroxymethyl)-2-(4-
nitrophenyl)ethyl]acetamide 
 13.46 321 
152 12 
110 23 Sulfadiazine (SDZ)                              
4-amino-N-pyrimidin- 2-yl-
benzenesulfonamide 
 2.39 251 
156 17 
186 17 Sulfamethazine (SMZ)               
2-(p-Aminobenzenesulfonamido)-4,6-
dimethylpyrimidine 
 4.29 279 
156 19 
136 32 Ethopabate (EPB)                      
methyl 4-(acetylamino)-2-
ethoxybenzoate 
 
14.16 238 
206 13 
128 24 
Clopidol (CLOP)                               
3,5-Dichloro-2,6-dimethyl-pyridin-4-ol  2.00 192 
101 26 
175 19 Carbadox (CAR)                  
methyl (2E)-2-[(1,4-dioxidoquinoxalin-
2-yl) 
methylene]hydrazinecarboxylate 
 2.65 263 
130 22 
151 18 
Dinitolmide (DIN)                       
2-Methyl-3,5-dinitrobenzamide  7.68 224 
181 12 
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Table 1b: Molecular Structures, Retention time (Rt), 
Precursor and Product ions and collision energies for all 
3 analytes. 
 
published methods exist for their analysis. The majority 
of methods published for the list of compounds specified 
in 2005/925/EC allow for the analysis of these 
compounds at levels relating to therapeutic level or in 
the mg kg-1  range while only a few allow for the analysis 
in the µg kg-1  range. Also, from examination of literature 
the majority of methods are single or dual analyte 
methods while very few are capable of analysing for a 
particular class of compounds.  
From a review of the literature it would seem there is a 
lack of published methods available that would help with 
the enforcement of Commission Recommendation 
2005/925/EC. In addition to this, methods available are 
for single analytes/classes at mg kg-1 range; often 
utilising large sample sizes which in turn need large 
amounts of solvent for extraction which can prove 
expensive and time consuming. Reports from the 
Screening and Identification Methods for official control 
of Banned Antibiotics and Growth promoters in 
Feedingstuffs study (SIMBAG-FEED study) suggested 
that methods be able to identify compounds to at least 5 
times lower than the lowest contents formerly described 
in the Directive 70/524/CEE. In many cases this was 
around the 1ppm range [de Jong, 2005]. To aid 
compliance with Commission Recommendation 
2005/925/EC there is a need for an efficient sensitive 
multi-class method to analyse for as many of the  
 
 
 
 
analytes listed in this recommendation as possible. To 
this end; this paper describes the analysis of 14 of these 
prohibited medicinal additives at 100 µg kg-1 levels in pig 
and poultry compound feed by LC-MS/MS utilising a 
small sample size of 2 g and an efficient sample 
extraction procedure. 
 
2.  Materials and Methods  
2.1 Chemicals and Reagents 
Dimetridazole (DMZ), ronidazole (RNZ), chloramphenicol 
(CAP), sulfadiazine (SDZ), sulfamethazine (SMZ), 
dinitolimide (DIN), ethopabate (ETHO), carbadox (CAR), 
clopidol (CLOP) and sulfaphenazole (SPZ) were 
purchased from Sigma (St. Louis, MO, USA), 
metronidazole (MNZ), ipronidazole(IPZ), d3-IPZ, d3-
DMZ, d3-RNZ were purchased from WITEGA 
Laboratorien (Berlin, Germany), d5-chloramphenicol 
were purchased from Dr Ehrenstorfer (Augsborg, 
Germany) and tylosin, virginiamycin and avilamycin were 
received from RIKILT (Wageningen, The Netherlands). 
Water was of LC-MS grade from Fluka (Germany). All 
other solvents were of LC grade and purchased from 
Reagecon (Clare, Ireland). Anhydrous Sodium sulphate 
Compound Molecular Structure Rt Precursor Ion (M/z) 
Product Ions 
(M/z) 
Collision 
Energy 
772 29 
Tylosin (TYL)  
 
 
14.03 917 
174 37 
355 20 
Viginiamycin (VIR)  
  
16.12 526 
508 15 
373 45 
Avilamycin (AVIL)             
  
14.89 791 
391 48 
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was AnalaR grade and purchased from Acros (Geel, 
Belgium). Individual stock standards of each analyte 
ranging between 0.25-1.00 mg ml-1 in ethanol were 
prepared and stored at 4˚C. A working standard solution 
(mixture of analytes) (10 ug mL-1) was prepared in 
acetonitrile and stored at 4º. Internal standards were 
prepared similarly except mixed standard was 200 ng 
mL-1. 
2.2 Instrumentation 
The LC-MS/MS system was a TSQ Quantum Ultra EMR 
coupled to a Finnigan Surveyor LC system. The 
instrument was controlled by Xcalibur software (Version 
1.5). Separation was achieved using a (100 ´ 2)mm, 
3mm particle size, Luna C18 column (Part No. 00D-
4251-B0) protected by a Security Guard guard cartridge 
system (20´2)mm, both supplied by Phenomenex. The 
oven temperature was set at 40ºC. The chromatographic 
separation was performed in gradient mode using water 
acidified with 0.2% acetic acid (mobile phase A) and 
acetonitrile acidified with 0.2% acetic acid (mobile phase 
B), at a flow rate of 0.25mL min-1. The initial conditions 
from 0-6min were 85% A. This was changed to 50% A 
over  2 minutes from 6-8min and was maintained until 10 
min. The conditions were changed again to 10% A over 
2 minutes from 10-12 min and these were maintained 
until 15.20 min. Finally the conditions returned to 85% A 
over 2.8 minutes from 15.20-18min and were maintained 
until the end of the run at 26min. Electrospray ionisation 
(ESI) was used in the MS with both positive and 
negative ionisation mode, with a spray voltage of 4350V 
and a cone temperature of 325 ºC. The individual 
precursor and products ions for each analyte with their 
respective collision energies are listed in Tables 1a and 
1b.  
2.3 Pig and Poultry Compound Feed Samples 
Different varieties of pig and poultry compound feed were 
sourced from various feed mills. These were milled upon 
receipt to 1mm using a Retsch SM 100 mill and stored in 
amber jars at 4ºC. Portions of these samples were 
analysed and those found to contain no detectable residues 
of the analytes of interest except for residues of 
sulfadiazine were used as blanks for the validation study. 
To ensure true robustness of the method a high number of 
different feed samples were used in validation. These 
included 18 different pig feeds and 18 different poultry 
feeds. Chromatograms of blank feed can be seen in Figure 
1b. 
 
 
2.4 Extraction 
Feed (2 g) was weighed into polypropylene centrifuge 
tubes (50 mL). The sample was fortified with mixed 
internal standard (50 µL) which corresponds to a 
concentration of 250 µg kg-1 of internal standard in the 
feed material. To this acetonitrile (12 mL) was added 
and the tubes were vortexed (20 secs). Anhydrous 
sodium sulphate (3.5 g) was added to this slurry which 
was shaken (30 mins) and centrifuged (5100rpm for 20 
min). The organic layer was transferred to a clean 
polypropylene tube (15 mL) and evaporated at 50ºC to 6 
mL under nitrogen. Hexane (5 mL) was added and the 
tubes contents were vortexed (30 secs) and centrifuged 
(3750 rpm for 20 min). The hexane layer was discarded 
and the extracts were evaporated to dryness at 50ºC 
under a nitrogen stream. The extract was reconstituted 
in water: acetonitrile (85:15, 800 µL) and vortexed 
thoroughly for 45 secs. The sample underwent an ultra-
centrifugation step at 13750 rpm for 30 mins. This 
centrifugation step separated the sample into two 
distinct layers. 200 µL of the clear lower layer 
(containing the analytes) was transferred into an LC-MS 
vial. An aliquot (20 µL) was injected onto the LC column. 
2.5  Matrix Extracted Calibration Curves 
Quantitation was carried out using matrix extracted 
calibration curves. Blank pig and poultry feed samples were 
used. These samples were fortified with mixed working 
standard and submitted to the full extraction procedure. 
Matrix extracted calibration curves were performed with 
every batch. Six different feed samples are fortified with 
internal standard and mixed working standard yielding a 
calibration range of 0 to 1000 µg kg-1 for all the 11 
quantitation analytes. Calibration curves were prepared by 
plotting the response factor (the ratio of peak area analyte 
over peak area of internal standard) against analyte 
concentration.  Five internal standards were used; d3- 
DMZ, d3-RNZ, d3-IPZ, d5-CAP and Sulfaphenazole. For 
those compounds for which no suitable deuterated internal 
standard could be acquired; MNZ, CLOP, DIN, ETHO and 
CAR, d3-DMZ was used as an internal standard. For each 
analyte; calibration curves were linear in the given range 
with a correlation coefficient of at least 0.98. In the case of 
the 3 qualitative analytes, TYL, VIR and OLA no suitable 
internal standard could be found. This resulted in poor 
linearity as matrix effects could not be corrected for in a 
repeatable manner. For these analytes six different feed 
samples were fortified; one at 0 µg kg-1 and five at the 100 
µg kg-1. d3-DMZ was used as an internal standard for these 
in order to compensate for any extraction errors. 
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Figure 1a: Chromatograms of Feed Fortified at a level 
equal to 100 µg kg-1 for all 14 compounds. 
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Figure 1b: Chromatograms of Blank Feed 
2.6 Method validation 
LC–MS/MS identification criteria were verified throughout 
the validation study by monitoring relative retention times 
and relative ion intensities. LC-MS/MS identification criteria 
as set out in the Commission Decision 2002/657 were 
verified throughout the validation of the method. 
Several method validation parameters were determined 
including linearity, specificity, trueness, precision 
(repeatability and within-laboratory reproducibility). 
Specificity was determined by analysing a number of 
different blank animal feed samples sourced from different 
mills. To investigate the linearity of the method, matrix-
extracted calibration curves were prepared and run with 
each of the validation batches to give 6 point calibration 
curves in the range of 0 to 1000 µg kg-1 for all eleven 
quantitation analytes. To ensure linearity across the range 
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of different feed samples that could be encountered for 
these species a different type of feed alternating between 
pig and poultry was used for each calibration point.   
Since no certified reference materials were available for the 
analytes and matrices of interest, the trueness from fortified 
negative samples was measured as an alternative to 
trueness. The trueness and precision of the method were 
determined through the analysis of negative pig and poultry 
compound feed fortified in six replicates at 100 µg kg-1, 500 
µg kg-1 and 1000 µg kg-1 with the eleven quantifiable 
analytes for a total of 18 samples. This was repeated on 
three separate days. For the three qualititative analytes all 
18 samples were fortified at 100 µg kg-1. The type of feed 
was varied for each of the six replicates in ordered to 
ensure that the method was fully fit for purpose. From these 
three separate validation days an estimation of trueness, 
precision (repeatability and within-laboratory reproducibility) 
and LC-MS/MS confirmatory criteria were all evaluated. 
 
3. Results and Discussion 
3.1 LC-MS/MS Optimisation 
The LC-MS/MS method was developed to provide 
confirmatory data for the analysis of 14 antibiotics in pig 
and poultry compound feed. The MS/MS fragmentation 
conditions were investigated and collision energies were 
optimised for each individual compound to give best 
response. For a method to be deemed confirmatory under 
Commission Decision 2002/657/EC it must yield 4 
identification points. In this method a precursor ion (parent 
mass) and two product ions (corresponding to strong and 
weak ion) were monitored for each analyte (Tables 1a and 
1b). This yielded 4 identification points (1 for the precursor 
ion and 1.5 for each product ion) hence it can be deemed a 
confirmatory method. In addition to this relative retention 
times and ion ratios were monitored for each compound 
and evaluated to ensure that they are within acceptable 
ranges as stated in CD 2002/657/EC. As this method 
involved positive and negative ionisation switching the 
MS/MS method had to be segmented. The LC gradient was 
optimised in order to have as an efficient run time as 
possible in order to allow successful segmentation of the 
MS/MS method. Only when the positive and negative 
ionisation switching was isolated to one segment was there 
enough data points for each peak. Lowering scan time and 
dwell time of the instrument was not sufficient to achieve 
this. For a method to achieve reliable quantitation each 
analyte peak should have at least 10-12 data points. The 
LC gradient along with segmentation permitted for the 
analysis of all 14 analytes in a complete run time of 26 
minutes with each peak having a minimum of 12 data 
points. 
3.2. Sample Extraction Development 
The development of the extraction method faced two major 
obstacles; one the need to extract a wide variety of 
analytes with a single extraction and the other the need to 
purify the sample sufficiently without losing the analytes in 
question. A variety of extraction solutions including water, 
acetonitrile and methanol and various mixtures of the three 
were tested. Immediately it was visibly evident that 
methanol and water extracted far more matrix contaminants 
than acetonitrile and this resulted in lower recoveries for the 
analytes using these extraction solvents. It was also 
observed that acetonitrile consistently extracted the broad 
range of analytes therefore acetonitrile was chosen as the 
extraction solvent. The next stage was to sufficiently clean 
up the acetonitrile extract in order to determine down to the 
levels of interest. The use of anhydrous sodium sulphate in 
sample clean up when extracting these analytes has been 
previously seen. [Stubbings et al., 2009]. Hence the use of 
anhydrous sodium sulphate was investigated followed by 
addition of a hexane wash step. This purification procedure 
sufficiently removed background interferences resulting in 
the fact that a SPE clean-up step was not needed. The 
purification was completed when the reconstituted extract 
underwent an ultracentrifugation step. This removed further 
interferences and also allowed all analytes to be 
determined at levels in the µg kg-1 range. 
3.3. Internal Standard Selection 
While the extraction method allowed all analytes to be seen 
in the µg kg-1 range the variability in sample recovery was 
noticeable from feed sample to feed sample. To overcome 
this problem the sourcing of suitable internal standards was 
pursued. In some cases deuterated analogues were 
available for the analytes such as d3-DMZ, d3-IPZ, d3-RNZ 
and d5-CAP. These corrected well for all variabilities 
encountered in extraction. Sulfaphenazole is a 
sulphonamide and it has been used as an internal standard 
for sulfonamides in previous work [McDonald et al., 2009]. 
This was used for SDZ and SMZ compounds and corrected 
sufficiently for them. Erythromycin was tried for use with 
VIR, TYL and AVIL but did not correct consistently well for 
them. As a last attempt the internal standards used for 
other compounds were used for the remaining compounds 
without internal standards. It was observed that d3-DMZ 
extracted consistently and as a result could be used as an 
internal standard for CLOP, CAR, DIN and ETH. This 
allowed for eleven compounds to be analysed 
quantitatively. For the remaining three compounds VIR, 
TYL and AVIL no suitable internal standard could be 
identified. Therefore the method could only be used as a 
qualitative extraction method for these compounds.  
3.4. Validation Approach Selection 
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As of yet no official EU validation protocol exists for the 
analysis of veterinary drugs in animal feed. Therefore a 
validation protocol was designed in order to best show that 
the method was fit for purpose. It was seen in development 
the variability due to the matrix feed is significant. In order 
to prove that the method would extract all analytes in a 
wide range of pig and poultry compound feed it was 
decided that feed samples would be varied as much as 
possible. For each of the calibration curve points a different 
feed would be used on each validation day to ensure 
linearity held through for all feeds. Eighteen samples were 
analysed on each day of the three validation days 
containing six different types of animal. A level of 100µg kg-
1
 was chosen as a reporting level and this is significantly 
lower for the majority of the analytes presented in this 
paper than observed in previous methods. SIMBAG study 
suggested levels around 1000 µg kg-1 but it was felt that as 
these compounds are banned they should not be present at 
any level. These compounds are prohibited for use as feed 
additives and therefore these compounds should not be 
present at any level and therefore the ALARA (as low as 
reasonably achievable) principle was adopted. Work carried 
out prior to validation indicated that a level of 100µg kg-1 
was achievable. This was chosen as it was felt that the 
method could be used to determine this level on a routine 
basis for all analytes. For the three qualitative analytes 
TYL, VIR, OLA it was decided that all eighteen samples on 
the three different days would be fortified at the reporting 
level of 100 µg kg-1. The measurement of uncertainty for 
each analyte would be calculated and added onto the 100 
µg kg-1 level and give us a value above which would result 
in a positive. For the eleven quantitative analytes a different 
approach was taken. The eighteen samples on the three 
days would be made up of six replicates of 100, 500 and 
1000µg kg-1. This was done in order to validate the method 
over the complete calibration range for which positive 
results might be obtained. Specificity, trueness, precision 
(repeatability and within-laboratory reproducibility); along 
with confirmatory criteria laid out Commission Decision 
2002/657 were determined during validation.  
3.5. Specificity 
The technique of LC-MS/MS itself offers a great deal of 
specificity and selectivity. To establish the specificity and 
selectivity of the method 18 blank pig and poultry 
compound feed samples and samples fortified with all 14 
analytes were analysed over the 3 validation days. All blank 
samples showed no interfering peaks in the area of interest 
for any of the analytes except for sulfadiazine. This is as a 
result of low levels of sulfadiazine found in the majority of 
feed samples available. Sulfadiazine is still permitted to be 
used in medicated feed and this might possibly be the 
reason for low levels been found in the feed. In order to 
correct for this, the feed samples were analysed prior to 
validation and the response observed for SDZ was 
subtracted from the results achieved during the validation 
procedure. Although this corrected the results somewhat, 
the variability in the background sulfadiazine resulted in 
worse validation results for this compound than the others. 
Chromatograms of blank feed and feed fortified at 100 µg 
kg-1 for each of the fourteen analytes are seen in Figure 1a 
and 1b.  
3.6. Linearity of Response 
The linearity of the chromatographic response was tested 
with matrix extracted calibration curves using six calibration 
points in the range of 0-1000µg kg-1 for all eleven 
quantitative analytes on each of the validation days. The 
regression coefficients for all the analytes on each of the 
validation days in were greater than 0.98. 
 3.7. Ion Ratios 
Two transition ions were monitored for each of the fourteen 
analytes. The most intense was used for quantitation. Ion 
ratios were calculated for all analytes. The ion ratio is a 
ratio of ion responses. The ratios of weak ion 
responses/strong ion responses are presented in Table 2. 
All ion ratios of samples were within tolerances as set out 
by European criteria when compared with standards used 
during validation. Control charts were used to ensure all ion 
ratios were acceptable. The example of metronidazole is 
seen in Figure 2.  
3.8. Relative Retention Times (RRT) 
RRTs were calculated for all fourteen analytes in this 
method by calculating the ratio of the retention time of the 
analyte over the retention time of its corresponding internal 
standards. The RRTs tolerance for LC-MS/MS of 2.5% was 
adhered to when standards were compared to samples in 
the validation runs. Control charts were again used to 
ensure all ion ratios were acceptable. The example of 
metronidazole is seen in Figure 3. The typical RRT for all 
the analytes are shown in Table 2.  
3.9. Trueness 
The trueness of the method was determined by fortifying 18 
replicate feed samples on three separate days. For the 
eleven quantitative analytes six replicates were fortified at 
100, 500, 1000µg kg-1 while the three qualitative analytes 
were all spiked at 100µg kg-1 for the 18 replicates. Mean 
corrected trueness (n=6) of the analytes, determined in the 
three separate validation batches, are shown in Table 2 
ranging between 89.2 and 103.3 for the fourteen analytes 
in pig and poultry feed. No recovery was determined as the 
use of internal standards means that each sample is 
individually corrected for. 
Prohibited Medicinal Additives in Feed 
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Table 2. Validation results for Accuracy, Repeatability, 
Reproducibility and Measurement Uncertainty (MU) and 
Confirmatory data of typical ion ratios and relative retention 
times(RRT) for all 14 analytes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Analyte 
Internal 
Standard 
Accuracy 
(%) 
Repeat 
%RSD 
Reprod 
%RSD 
M U 
(%) 
Typical 
RRT 
Typical 
Ion Ratio 
Cut-Off 
Level 
µg/kg 
DMZ DMZ-d3 98.9 4.5 8.9 27 1.0100 0.2344 100 
RNZ RNZ-d3 99.1 6.3 9.0 27 1.0053 0.0395 100 
MNZ DMZ-d3 102.5 5.8 9.3 28 0.6911 0.2964 100 
IPZ IPZ-d3 99.4 4.3 7.2 24 1.0164 0.8382 100 
SDZ SPZ 101.4 23.3 28.0 84 0.1666 0.4667 100 
SMZ SPZ 101.4 16.8 20.6 55 0.2987 0.2815 100 
CAR DMZ-d3 99.9 12.6 13.9 42 0.9466 0.1610 100 
CAP CAP-d5 101.2 11.4 12.0 36 1.0082 0.8108 100 
CLOP DMZ-d3 103.3 10.8 16.0 48 0.7125 0.3653 100 
DINIT DMZ-d3 96.3 7.7 14.8 44 2.7345 0.1880 100 
ETH DMZ-d3 99.4 9.1 16.3 49 5.0406 0.5094 100 
TYL DMZ-d3 95.6 16.8 21.8 69 5.0000 0.7275 169 
VIR DMZ-d3 100.0 22.7 22.9 65 5.7381 0.3777 165 
AVIL DMZ-d3 89.2 21.1 22.0 66 5.2961 0.4851 166 
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Figure 2. Control Chart for Ion Ratio of Metronidazole  
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Metronidazole 
Sample 
Strong Ion 
Peak Area 
Weak Ion 
Peak Area  Ion Ratio 20%+ 20%- 
Std 100 µg kg-1 15194729 4752084 0.3127 0.3556 0.2371 
Std 250 µg kg-1 42333522 12107683 0.2860 0.3556 0.2371 
Std 500 µg kg-1 72310544 20962631 0.2899 0.3556 0.2371 
Std 750 µg kg-1 111573188 33615028 0.3013 0.3556 0.2371 
Std 1000 µg kg-1 141124965 41197657 0.2919 0.3556 0.2371 
Level 1 A 15930883 4802808 0.3015 0.3556 0.2371 
Level 1 B 13779107 4100715 0.2976 0.3556 0.2371 
Level 1 C 15060999 4687121 0.3112 0.3556 0.2371 
Level 1 D 14015787 4045653 0.2886 0.3556 0.2371 
Level 1 E 14936729 4494700 0.3009 0.3556 0.2371 
Level 1 F 15109412 4330588 0.2866 0.3556 0.2371 
Level 2 A 82300381 23812667 0.2893 0.3556 0.2371 
Level 2 B 55668164 16886535 0.3033 0.3556 0.2371 
Level 2 C 98201444 27970852 0.2848 0.3556 0.2371 
Level 2 D 86217956 24778305 0.2874 0.3556 0.2371 
Level 2 E 88044794 25699990 0.2919 0.3556 0.2371 
Level 2 F 88971771 27257657 0.3064 0.3556 0.2371 
Level 3 A 183983033 50847934 0.2764 0.3556 0.2371 
Level 3 B 157024199 45227252 0.2880 0.3556 0.2371 
Level 3 C 170214626 50069929 0.2942 0.3556 0.2371 
Level 3 D 170597905 48706960 0.2855 0.3556 0.2371 
Level 3 E 177451858 50805992 0.2863 0.3556 0.2371 
Level 3 F 163816078 47947886 0.2927 0.3556 0.2371 
 
Average Std Ion Ratio: 0.2964 
Average + 20%   : 0.3556 
Average – 20%   : 0.2371  
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Figure 3. RRT Control Chart for Metronidazole 
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Time  
Retention Time 
of Internal 
Standard 
Relative 
Retention Time 
(RRT) 2.5%+ 2.5%- 
Std2 Std 100 1.94 2.82 0.6879 0.7084 0.6738 
Std3 Std 250 1.95 2.80 0.6964 0.7084 0.6738 
Std4 Std 500 1.94 2.82 0.6879 0.7084 0.6738 
Std5 Std 750 1.94 2.80 0.6929 0.7084 0.6738 
Std6 Std 1000 1.94 2.81 0.6904 0.7084 0.6738 
  Level 1 A 1.95 2.82 0.6915 0.7084 0.6738 
  Level 1 B 1.94 2.82 0.6879 0.7084 0.6738 
  Level 1 C 1.94 2.80 0.6929 0.7084 0.6738 
  Level 1 D 1.93 2.80 0.6893 0.7084 0.6738 
  Level 1 E 1.95 2.80 0.6964 0.7084 0.6738 
  Level 1 F 1.94 2.82 0.6879 0.7084 0.6738 
  Level 2 A 1.94 2.82 0.6879 0.7084 0.6738 
  Level 2 B 1.94 2.82 0.6879 0.7084 0.6738 
  Level 2 C 1.94 2.82 0.6879 0.7084 0.6738 
  Level 2 D 1.94 2.82 0.6879 0.7084 0.6738 
  Level 2 E 1.94 2.82 0.6879 0.7084 0.6738 
  Level 2 F 1.94 2.82 0.6879 0.7084 0.6738 
  Level 3 A 1.96 2.82 0.6950 0.7084 0.6738 
  Level 3 B 1.94 2.80 0.6929 0.7084 0.6738 
  Level 3 C 1.94 2.80 0.6929 0.7084 0.6738 
  Level 3 D 1.94 2.80 0.6929 0.7084 0.6738 
  Level 3 E 1.95 2.82 0.6915 0.7084 0.6738 
  Level 3 F 1.95 2.82 0.6915 0.7084 0.6738 
 
Average RRT: 0.6911 
 
Average + 2.5%: 0.7081 
Average – 2.5%: 0.6738 
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3.10 Precision (Repeatability and within-lab 
Reproducibility) 
Repeatability (within-day) and within-laboratory 
reproducibility (different days and operators) were 
determined by calculating relative standard deviations 
(RSD, %) for the repeated measurements. Overall 
repeatability (RSD, %) and within-laboratory reproducibility 
(RSD, %) ranged from 4.3 to 23.3% and from 7.2 to 28.0%, 
respectively, for all analytes (Table 2). 
The usefulness of suitable deuterated internal standards is 
demonstrated in the acceptable results for repeatability and 
within-laboratory reproducibility obtained for DMZ, RNZ, 
IPZ and CAP. Although deuterated analogues could not be 
obtained by our laboratory for use as internal standards for 
over half of the analytes investigated, acceptable 
repeatability and within-laboratory reproducibility is 
obtained by using the d3-DMZ for MNZ, CLOP, DINIT, 
ETH, CAR and using sulfaphenazole for SMZ. Less 
favorable is the situation for SDZ. Rather high RSD values 
were obtained for both the repeatability and within-
laboratory reproducibility of SDZ (between 20 and 28%), 
even when applying correction by means of an internal 
standard (sulfaphenazole). This is as a result of the 
variability for the feed sample due to the low levels of SDZ 
present in the feed.  
3.11. Measurement of Uncertainty 
The measurement uncertainty (MU) was estimated by 
taking into account the within laboratory reproducibility over 
days 1, 2 and 3. This value was multiplied by  a  coverage  
factor  of  three  to  give  an  overall  figure  for  the  MU. 
This approach of using the within laboratory reproducibility 
as a good estimator of measurement of uncertainty is taken 
from the SANCO/2004/2726rev4 document. It recommends 
using the within laboratory reproducibility and using a 
coverage factor of 2.33 to estimate expanded uncertainty, 
however it was felt that not all the environmental factors 
that could be varied over the course of the validation were  
examined. Therefore  a  coverage factor of 2.33 may 
underestimate  the true uncertainty of the method and 
instead a value of 3 was  chosen to  give  a  more  realistic  
value  for  the  true  uncertainty. Values for MU are seen in 
Table 2 and lie between 24 and 84% for all the analytes. 
Higher MUs are seen in some compounds with no 
deuterated analogues for use as internal standards which is 
expected. In particular the MU for SDZ (84%) is the highest 
observed for any of the analytes investigated due to 
problems with low levels of SDZ observed in the majority of 
feed used. This resulted in greater variability in results 
achieved for SDZ and in turn increased its MU. 
 
4. Conclusions 
The objective of this work was to develop a rapid multi-
class confirmatory method capable of analysing for fourteen 
prohibited medicinal additives in pig and poultry compound 
feed at 100 µg kg-1 and to validate in such a way as to best 
show the method as fit for purpose. This was successfully 
completed to allow for the quantification of 10 analytes and 
qualitative analysis of 4 analytes. 
The method can be considered as rapid, as it utilises an 
efficient extraction protocol without the use of large sample 
sizes, extraction volumes and SPE. It also utilises 
chromatography which separates all analytes in a total run 
time of only 26 minutes. The method permits the analysis of 
14 medicinal additives in pig and poultry compound feed 
which has not been seen in literature before. 
The obtained confirmatory criteria of ion ratios and relative 
retention times fulfill the requirements laid down in 
Commission Decision 2002/657/EC. The calculation of all 
relevant performance characteristics was performed during 
validation. This study shows that the developed method 
meets the desired sensitivity of 100 µg kg-1 for all the 
compounds. The method performs satisfactorily in terms of 
trueness and repeatability for each of the analytes 
investigated with the exception of sulfadiazine due to the 
utilisation of five different internal standards. The values 
achieved for trueness, %RSD and measurement of 
uncertainty all fall within acceptable ranges except for 
sulfadiazine. The applicability of the method for use on 
various types of pig and poultry compound feed was 
demonstrated by the satisfactory results obtained from the 
validation. The validation data shows that the method 
allows for the quantitation of 10 analytes and the qualitative 
analysis of 3 analytes. While sulfadiazine was validated in 
order to be quantified the validation results achieved were 
not acceptable. This is as a result of varying background 
sulfadiazine in the feeds that were used in validation. That 
said, the reduced number of analytical steps within the 
method makes it very amenable for high through-put 
regulatory monitoring of these compounds and enforcing 
Commission Recommendation 2005/925/EC.  
The method developed in this study is an improvement on 
existing methods as it allows for the analysis of an 
increased number of analytes in this matrix. It also allows 
for reduced sample preparation times and solvent usage 
than other published methods.The objective of this work 
was to develop a rapid confirmatory method capable of 
identifying, confirming and quantifying eleven nitroimidazole 
compounds in egg at µg kg-1 levels and to validate 
according to the requirements in Commission Decision 
2002/657/EC and this was successfully completed.  
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The method can be considered as rapid, as it utilises only a 
hexane wash and omits the use of the time consuming SPE 
step, it also utilises chromatography which separates all 
analytes in a total run time of only 20 minutes. The method 
includes 11 nitroimidazole compounds including seven that 
are suggested by the CRL in Berlin to be analysed as well 
as other nitroimidazoles that are rarely if at all analysed 
such as tinidazole, ornidazole and carnidazole. 
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